142 related articles for article (PubMed ID: 3096952)
1. Cytomorphological lesions induced by chemotherapeutic agents in transitional cell carcinoma in vitro.
Weaver DJ; Barrett BA; Ross G; Adelstein EH
In Vitro Cell Dev Biol; 1986 Nov; 22(11):653-60. PubMed ID: 3096952
[TBL] [Abstract][Full Text] [Related]
2. [Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Uchibayashi T
Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1606-20. PubMed ID: 6202921
[No Abstract] [Full Text] [Related]
3. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Groos E; Masters JR
J Urol; 1986 Aug; 136(2):399-402. PubMed ID: 3090275
[TBL] [Abstract][Full Text] [Related]
4. The effect of pH on the in vitro colony forming ability of transitional cell carcinoma cells treated with various chemotherapeutic agents: implications for in vivo therapy.
Tarkington M; Sommers CL; Gelmann EP; Tefft MC; Lynch JH
J Urol; 1992 Feb; 147(2):511-3. PubMed ID: 1732633
[TBL] [Abstract][Full Text] [Related]
5. The ultrastructure of transitional cell carcinomas of the human urinary bladder treated with ethoglucid or mitomycin.
Stewart RJ; Lawson AH; Weaver JP
J Urol; 1988 Jun; 139(6):1355-8. PubMed ID: 3373614
[TBL] [Abstract][Full Text] [Related]
6. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
Okamoto E; Kinne RK; Sökeland J
J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
[TBL] [Abstract][Full Text] [Related]
7. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
[TBL] [Abstract][Full Text] [Related]
8. [Chemosensitivity test on superficial urinary bladder cancer using the dye exclusion assay--model of intravesical chemotherapy].
Koseki K; Irisawa C; Shiraiwa Y
Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):268-73. PubMed ID: 1904118
[TBL] [Abstract][Full Text] [Related]
9. Use of intravesical cisplatin and mitomycin-C for recurrent transitional cell carcinoma of bladder refractory to thiotepa.
Mobley WC; Loening SA; Narayana AS; Culp DA
Urology; 1986 Apr; 27(4):335-9. PubMed ID: 3083555
[TBL] [Abstract][Full Text] [Related]
10. In vitro chemosensitivity of human bladder cancer.
Weisenthal LM; Lalude AO; Miller JB
Cancer; 1983 Apr; 51(8):1490-6. PubMed ID: 6186358
[TBL] [Abstract][Full Text] [Related]
11. The effect of chemotherapeutic agents on the ultrastructure of transitional cell carcinoma in tissue culture.
Weaver D; Khare N; Haigh J; Adelstein E; Oxenhandler R; Ross G
Invest Urol; 1980 Jan; 17(4):288-92. PubMed ID: 6766125
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.
Yen WC; Au JL
Pharm Res; 1997 Feb; 14(2):241-5. PubMed ID: 9090717
[No Abstract] [Full Text] [Related]
13. Distilled water versus chemotherapeutic agents for transitional bladder carcinoma.
Levin DR; Moskovitz B
Eur Urol; 1986; 12(6):418-21. PubMed ID: 3102241
[TBL] [Abstract][Full Text] [Related]
14. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
Hardeman SW; Perry A; Soloway MS
J Urol; 1988 Aug; 140(2):289-92. PubMed ID: 3135420
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravesical instillation of antitumor chemotherapeutic agents on bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Ohtani M; Fukushima S; Okamura T; Sakata T; Ito N; Koiso K; Niijima T
Cancer; 1984 Oct; 54(8):1525-9. PubMed ID: 6434176
[TBL] [Abstract][Full Text] [Related]
16. Approaches to the treatment of bladder cancer at Stanford.
Torti FM
Cancer Chemother Pharmacol; 1987; 20 Suppl():S63-6. PubMed ID: 2444355
[TBL] [Abstract][Full Text] [Related]
17. In vitro investigations of new therapeutic agents on bladder tumor cell lines.
Kugler A; Haschemi R; Zöller G; Gross AJ; Kallerhoff M; Ringert RH
Urol Res; 1997; 25(4):247-50. PubMed ID: 9286032
[TBL] [Abstract][Full Text] [Related]
18. The effect of intravesical instillations of thiotepa, mitomycin C, and adriamycin on normal urothelium: an experimental study in rats.
Friedman D; Mooppan UM; Rosen Y; Kim H
J Urol; 1991 May; 145(5):1060-3. PubMed ID: 1901918
[TBL] [Abstract][Full Text] [Related]
19. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Groos E; Walker L; Masters JR
Cancer; 1986 Sep; 58(6):1199-203. PubMed ID: 3091241
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide.
Mizutani Y; Fukumoto M; Bonavida B; Yoshida O
Cancer; 1994 Nov; 74(9):2546-54. PubMed ID: 7923012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
